Medicare Enrolled

Dr. Patricia Kachur

Rheumatology · Pensacola, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
8333 N DAVIS HWY, Pensacola, FL 32514
8504748387
In practice since 2015 (11 years)
NPI: 1477947489 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kachur from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kachur? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kachur

Dr. Patricia Kachur is a rheumatology specialist in Pensacola, FL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Kachur performed 53,063 Medicare services across 1,747 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kachur received a total of $17,671 from 40 pharmaceutical and/or device companies across 584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kachur is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 36% volume in FL $17,671 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 133842 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
53,063
Medicare services
Top 36% in FL for rheumatology
1,747
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,824 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria) 26,659 $10 $41
Denosumab injection (Prolia/Xgeva) 13,320 $18 $36
Infliximab infusion (Remicade) 5,780 $26 $115
Injection, rituximab, 10 mg 3,500 $64 $191
Office visit, established patient (30-39 min) 1,475 $90 $195
Steroid injection (triamcinolone) 386 $1 $4
Drug injection, under skin or into muscle 287 $11 $28
Complete ultrasound scan of joint 258 $9 $131
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 240 $48 $143
Administration of chemotherapy into vein, 1 hour or less 234 $98 $278
Administration of chemotherapy into vein, each additional hour 205 $21 $61
Injection, zoledronic acid, 1 mg 175 $6 $150
Bone density scan (DEXA) 174 $36 $74
Injection of additional new drug or substance into vein 83 $12 $35
New patient office visit (45-59 min) 67 $121 $247
New patient office visit, complex (60-74 min) 41 $173 $335
Injection, diphenhydramine hcl, up to 50 mg 40 $1 $2
Joint injection, major joint 37 $56 $123
Injection, methylprednisolone sodium succinate, up to 125 mg 33 $4 $12
Office visit, established patient (20-29 min) 28 $64 $137
Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free 22 $33 $56
Flu vaccine administration 19 $30 $37
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
61.6% high complexity
35.0% medium
3.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$17,671
Total received (2018-2024)
Avg $2,524/year across 7 years
Top 27% in FL for rheumatology
40
Companies
584
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,045 (73.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,556 (25.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$70 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,268
2023
$4,028
2022
$5,927
2021
$570
2020
$226
2019
$2,438
2018
$214

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$3,345
ABBVIE INC.
$2,559
Amgen Inc.
$2,090
Celgene Corporation
$1,904
Novartis Pharmaceuticals Corporation
$1,088
GlaxoSmithKline, LLC.
$834
UCB, Inc.
$798
Mallinckrodt Hospital Products Inc.
$608
Boehringer Ingelheim Pharmaceuticals, Inc.
$586
PFIZER INC.
$463
Radius Health, Inc.
$382
Lilly USA, LLC
$343
Aurinia Pharma U.S., Inc.
$320
AstraZeneca Pharmaceuticals LP
$274
Horizon Therapeutics plc
$259
AbbVie, Inc.
$208
Alexion Pharmaceuticals, Inc.
$177
GENZYME CORPORATION
$175
E.R. Squibb & Sons, L.L.C.
$167
Inari Medical, Inc.
$130
Lantheus Medical Imaging, Inc.
$113
Fresenius Kabi USA, LLC
$113
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$100
AbbVie Inc.
$98
Octapharma USA, Inc.
$80
Sandoz Inc.
$57
Kiniksa Pharmaceuticals International, plc
$51
Grifols USA, LLC
$41
Ultragenyx Pharmaceutical Inc.
$41
Sobi, Inc
$36
Genentech USA, Inc.
$34
SCILEX PHARMACEUTICALS INC.
$30
Kyowa Kirin, Inc.
$29
United Therapeutics Corporation
$25
Regeneron Healthcare Solutions, Inc.
$24
Organon LLC
$22
Mallinckrodt Enterprises LLC
$20
Bioventus LLC
$16
Esperion Therapeutics, Inc.
$16
Organon Llc
$15
Top 3 companies account for 45.2% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DEFINITY · DUPIXENT · DUROLANE · ELIQUIS · EVENITY · Enbrel · FASENRA · FLOWTRIEVER CATHETER · HADLIMA · HUMIRA · HYRIMOZ · IDACIO · ILARIS · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LifeVest · NEXLETOL · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · Prolastin-C Liquid · RINVOQ · Repatha · S · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · TYVASO · Tavneos · Tymlos · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $33 per 100 Medicare services performed
Looking for a rheumatology specialist in Pensacola?
Compare rheumatologists in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
14
Per 100K population
4.3
County median income
$65,715
Nearest hospital
HCA FLORIDA WEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kachur is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kachur experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Kachur performed 26,659 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kachur receive payments from pharmaceutical companies?
Yes. Dr. Kachur received a total of $17,671 from 40 companies across 584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kachur's costs compare to other rheumatologists in Pensacola?
Dr. Kachur's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kachur) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →